MARKET

HBIO

HBIO

Harvard Biosci
NASDAQ
0.5370
-0.0068
-1.25%
Opening 11:48 02/12 EST
OPEN
0.5418
PREV CLOSE
0.5438
HIGH
0.5650
LOW
0.5343
VOLUME
138.69K
TURNOVER
--
52 WEEK HIGH
1.490
52 WEEK LOW
0.2813
MARKET CAP
24.01M
P/E (TTM)
-0.4401
1D
5D
1M
3M
1Y
5Y
1D
Harvard Bioscience outlines strategy for growth
TipRanks · 2d ago
Harvard Bioscience Reports Q4 Preliminary Revenue Of $23.7M
Benzinga · 2d ago
HARVARD BIOSCIENCE INC - EXPECTS YEAR OVER YEAR REVENUE GROWTH AND MID-TO HIGH-SINGLE-DIGIT EBITDA GROWTH IN 2026
Reuters · 2d ago
*Harvard Bioscience Sees 4Q Rev $22.5M-$24.5M >HBIO
Dow Jones · 2d ago
Press Release: Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
Dow Jones · 2d ago
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
Barchart · 2d ago
Weekly Report: what happened at HBIO last week (0202-0206)?
Weekly Report · 3d ago
Weekly Report: what happened at HBIO last week (0126-0130)?
Weekly Report · 02/02 10:17
More
About HBIO
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.

Webull offers Harvard Bioscience Inc stock information, including NASDAQ: HBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HBIO stock methods without spending real money on the virtual paper trading platform.